Distinguished University Professor
Professor, Department of Neurosciences
Professor, Department of Psychiatry and Behavioral Sciences |
EDUCATION | Western Washington State University, Bellingham, WA | B.S. | 1974 | Biology | | University of Washington, Seattle, WA | Ph.D. | 1980 | Pharmacology | | University of North Carolina, Chapel Hill, NC | Postdoctoral | 1982 | Neuropharmacology |
PROFESSIONAL EXPERIENCE | 1982-1984 | Assistant Professor, Pharmacology, Louisiana State University Medical Center, New Orleans, LA | | 1984-1987 | Assistant Professor, Department of Comparative Anatomy, Pharmacology, & Physiology, Washington State University, Pullman, WA | | 1987-1991 | Associate Professor, Department of Comparative Anatomy, Pharmacology, & Physiology, Washington State University, Pullman, WA | | 1990-1998 | Director, Alcohol and Drug Abuse Program, Washington State University, Pullman, WA
| | 1991-1998 | Professor, Department of Comparative Anatomy, Pharmacology, & Physiology, Washington State University, Pullman, WA | | 1995-1996 | Visiting Professor, Department of Anatomy & Histology, The Flinders University School of Medicine, Adelaide, SA, Australia | | 1998-present | Professor and Chair, Department of Neurosciences, MUSC, Charleston, SC
| | 2000-2003 | Co-Director, Neuroscience Institute, MUSC, Charleston, SC |
AWARDS AND HONORS | 1980 | NIMH Postdoctoral Trainee Fellowship | | 1990 | NIDA Research Career Development Award | | 1993 | Smith-Kline-Beecham Research Excellence Award | | 1993 | Plenary Lecture, Summer Neuropeptide Conference, Martha's Vineyard | | 1995 | Fogarty Senior Fellowship | | 1995 | Plenary Lecture, Dopamine Symposium, Taipei, Taiwan | | 1996 | Daniel H Efron Award (American College of Neuropsychopharmacology) | | 1996 | Washington State Sahlin Faculty Research Excellence Award | | 1996 | Plenary Lecture, 7th In Vivo Monitoring of Molecules in Neuroscience, Tenerife, Spain | | 1996 | Grass Traveling Scientist Award, Indianapolis Chapter of Society for Neuroscience, Indianapolis | | 1998 | Elliot Stellar Lecture, University of Pennsylvania, Philadelphia, PA | | 1999 | Grass Traveling Scientist Award, Nashville Chapter of Society for Neuroscience, Nashville, TN | | 1999 | Plenary Lecture, American Neuropsychiatric Society, Fort Myers, FL | | 1999 | Grass Traveling Scientist Award, Mississippi Chapter of Society for Neuroscience, Jackson | | 2001 | Honorary Professor of Neurological Sciences, Nanjing Medical University, China | | 2001 | Grass Traveling Scientist Award, Kentucky Chapter of Society for Neuroscience, Lexington, KY | | 2001 | Plenary Lecture, Neuroscience Hellenic Society, San Diego, CA | | 2001-2011 | NIDA Merit Award for 2001-2011
| | 2002 | Wheeler Plenary Speaker, 33rd International Narcotics Research Conference, Pacific Grove | | 2002 | Plenary Lecture, Society for Neuroimmunology, Tampa, FL | | 2002 | Appointed to the National Advisory Council on Drug Abuse | | 2003 | Distinguished University Professor, MUSC | | 2003 | Grass Traveling Scientist Award, Michigan Chapter Society for Neuroscience, Detroit, MI | | 2003 | Appointed to NARSAD Scientific Advisory Board | | 2003 | Appointed to the Fundacion Cerebro y Mente Advisory Board | | 2004 | Keynote Lecture, University of Cincinnati Medical School 25th Annual Research Forum | | 2004 | Sigma Xi Banquet Speaker, The Citadel, Charleston, SC | | 2005 | Distinguished Basic Science Scholar on the Addictions (Am J Addict) | | 2005 | Plenary Speaker, Research Society for Alcoholism, Santa Barbara, CA | | 2005 | Elected to ACNP Council | | 2005 | Appointed as Chair of the NIDA Medications Development SAB | | 2006 | Plenary Lecture, International Neuroscience Winter Conference, Solden, Austria | | 2006 | Special Lecture, Society for Neuroscience Meeting, Atlanta, GA |
PUBLICATIONS (2006-present)
Carr D & Kalivas PW. Orexin: A gatekeeper of addiction. Nature Medicine 12(3):274-276, 2006. Champtiaux N, Kalivas PW & Bardo MT. Contribution of dihydro-beta-erythroidine sensitive nicotinic acetylcholine receptors in the ventral tegmental area to cocaine-induced behavioral sensitization in rats. Behavior Brain Research 168(1):120-126, 2006. Kalivas PW & Hu X-T. Exciting inhibition in psychostimulant addiction. Trends in Neurosciences 29(11):610-616, 2006. Kalivas PW, Peters J & Knackstedt L. Animal models and brain circuits in drug addiction. Molecular Interventions 6(6):339-344, 2006. LaRowe SD, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, Saladin M, McRae A & Brady K. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. American Journal on Addictions 15(1):105-110, 2006. Melendez RI, Middaugh LD & Kalivas PW. Development of an alcohol deprivation and escalation effect in C57BL/6J mice. Alcoholism: Clinical & Experimental Research 30(12):2017-2025, 2006. Nogueira L, Kalivas PW & Lavin A. Long-term neuroadaptations produced by withdrawal from repeated cocaine treatment: Role of dopaminergic receptors in modulating cortical excitability. Journal of Neuroscience 26(47):12308-12313, 2006. Peters J & Kalivas PW. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats. Psychopharmacology 186(2):143-149, 2006. Shih AY, Erb H, Sun X, Toda S, Kalivas PW & Murphy TH. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. Journal of Neuroscience 26(41):10514-10523, 2006. Szumlinski KK, Abernathy KE, Oleson EB, Klugmann M, Lominac KD, He D-Y, Ron D, During M & Kalivas PW. Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology 31(4):768-777, 2006. Szumlinski KK, Kalivas PW & Worley PF. Homer proteins: Implications for neuropsychiatric disorders. Current Opinion in Neurobiology 16(3):251-257, 2006. Toda S, Shen HW, Peters J, Cagle S & Kalivas PW. Cocaine increases actin cycling: Effects in the reinstatement model of drug seeking. Journal of Neuroscience 26(5):1579-1587, 2006. Kalivas PW. Neurobiology of cocaine addiction: Implications for new pharmacotherapy. American Journal on Addictions 16(2):71-78, 2007. Knackstedt LA & Kalivas PW. Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization. Journal of Pharmacology & Experimental Therapeutics 322(3):1103-1109, 2007. Larowe SD, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A, Brady K, Kalivas PW & Malcolm R. Is cocaine desire reduced by N-acetylcysteine? American Journal of Psychiatry 164(7):1115-1117, 2007. Mardikian PN, Larowe SD, Hedden S, Kalivas PW & Malcolm RJ. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study. Progress in Neuro Psychopharmacology & Biological Psychiatry 31(2):389-394, 2007. Pacchioni AM, Vallone J, Melendez RI, Shih A, Murphy TH & Kalivas PW. Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity. Brain Research 1127(1):26-35, 2007. Shen H, Korutla L, Champtiaux N, Toda S, LaLumiere R, Vallone J, Klugmann M, Blendy JA, Mackler SA & Kalivas PW. NAC1 regulates the recruitment of the proteasome complex into dendritic spines. Journal of Neuroscience 27(33):8903-8913, 2007. Zhou W, Liu H, Zhang F, Tang S, Zhu H, Lai M & Kalivas PW. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues. Neuroscience 144(4):1209-1218, 2007. |
